Related Experiment Video

Updated: Aug 17, 2026

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
07:54

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

Immunological aspects of microglia: relevance to Alzheimer's disease

E N Benveniste1, V T Nguyen, G M O'Keefe

  • 1Department of Cell Biology, The University of Alabama at Birmingham, 1918 University Boulevard, MCLM 395, Birmingham, AL 35294-0005, USA. tika@uab.edu

Neurochemistry International
|October 2, 2001
PubMed

Insights

Alzheimer's disease (AD) involves brain inflammation driven by beta-amyloid. Understanding microglial activation and suppression pathways offers potential therapeutic strategies for AD treatment.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Alzheimer's disease (AD) is a leading cause of dementia in the elderly.
  • Neuropathological hallmarks include beta-amyloid (Aβ) plaques and activated microglia.
  • These features suggest localized inflammation within the AD brain.

Purpose of the Study:

  • To review mechanisms of microglial activation in AD.
  • To emphasize the role of Aβ protein and pro-inflammatory cytokines.
  • To describe pathways for suppressing microglial activation.

Main Methods:

  • Review of existing literature on microglial activation in Alzheimer's disease.
  • Analysis of the role of beta-amyloid and inflammatory mediators.
  • Examination of immunosuppressive cytokine pathways.

Main Results:

  • Microglial activation is a key feature of AD neuropathology.
  • Beta-amyloid and pro-inflammatory cytokines drive microglial activation.
  • Immunosuppressive cytokines offer potential pathways to modulate this response.

Conclusions:

  • Microglial-mediated inflammation is integral to AD pathophysiology.
  • Targeting microglial activation represents a promising therapeutic avenue for AD.

More Related Videos

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain10:40

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

Obtaining Human Microglia from Adult Human Brain Tissue09:41

Obtaining Human Microglia from Adult Human Brain Tissue

Published on: August 30, 2020

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...